{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:29:36Z","timestamp":1777991376224,"version":"3.51.4"},"reference-count":56,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2020,3,12]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Current study focuses on the formulation and characterization of lipophilic and\nhydrophilic gel formulations of nifedipine to treat anal fissure via anodermal application.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Lipophilic gels were prepared with Aerosil grades as gelling agents in bulk oils. Polyethylene\nglycols, hydroxypropyl methylcellulose, and Carbopol\u00ae 974P were used as gelling agents in water and\npropylene glycol for forming hydrophilic gels. The effect of repeated Freeze-Thaw Cycles (FT-C) on\nmicrostructures of the gels was investigated by examining viscosity, rheology and textural properties.\nAerosil 200 containing lipophilic gels exhibited thixotropic behavior with plastic flow properties and\nhigher viscosities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Accordingly, their compressibility and adhesiveness increased. FT-C caused notable changes in\nmicrostructures and textural properties of the lipophilic gels excluding the formulation containing\nAerosil 200-in-isopropyl myristate. Among the hydrophilic gels, the viscosity of Carbopol\u00ae 974P gels\nincreased depending on the amount of polymer, triethanolamine and water; these gels featured plastic\nflow without thixotropic behavior. Their compressibility and adhesiveness were higher than other gel\nformulations with stable post-FT-C characteristics. The higher flux values of nifedipine were observed\nfrom water containing Carbopol\u00ae 974P gel.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results of the stability tests showed that the Carbopol\u00ae 974P gel had a longer shelf life\nthan the Aerosil 200-in-isopropyl myristate gel.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201817666200102125242","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T18:17:40Z","timestamp":1578075460000},"page":"126-139","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and <i>In vitro<\/i> Evaluation of Nifedipine Gel Formulations for Anorectal Applications"],"prefix":"10.2174","volume":"17","author":[{"given":"Nuray","family":"Bagci","sequence":"first","affiliation":[{"name":"Turkish Medicines and Medical Devices Agency (TMMDA), Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerrin Sezgin","family":"Bayindir","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Inal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurten","family":"Altanlar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-1842","authenticated-orcid":true,"given":"Nilufer","family":"Yuksel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0035-1570390","volume":"29","author":"Beaty J.S.","year":"2016","unstructured":"Beaty J.S.; Shashidharan M.; Anal fissure. Clin Colon Rectal Surg 2016,29(1),30-37","journal-title":"Clin Colon Rectal Surg"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10151-011-0683-7","volume":"15","author":"Altomare D.F.","year":"2011","unstructured":"Altomare D.F.; Binda G.A.; Canuti S.; Landolfi V.; Trompetto M.; Villani R.D.; The management of patients with primary chronic anal fissure: A position paper. Tech Coloproctol 2011,15(2),135-141","journal-title":"Tech Coloproctol"},{"key":"ref=3","first-page":"136","volume":"44","author":"Leong A.P.K.","year":"2003","unstructured":"Leong A.P.K.; Pharmacological treatment of anal fissure-a future role in primary care. Singapore Med J 2003,44(3),136-137","journal-title":"Singapore Med J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5772\/33713","author":"Klin B.","year":"2012","unstructured":"Klin B.; Abu-Kishk I.; Efrati Y.; Lotan G.;  Complementary Pediatrics 2012,53-70","journal-title":"Complementary Pediatrics"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2036.2006.02990.x","volume":"24","author":"Steele S.R.","year":"2006","unstructured":"Steele S.R.; Madoff R.D.; Systematic review: The treatment of anal fissure. Aliment Pharmacol Ther 2006,24(2),247-257","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/bmj.292.6529.1167","volume":"292","author":"Jensen S.L.","year":"1986","unstructured":"Jensen S.L.; Treatment of first episodes of acute anal fissure: Prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. Br Med J (Clin Res Ed) 1986,292(6529),1167-1169","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1308\/003588407X202137","volume":"89","author":"Bhardwaj R.","year":"2007","unstructured":"Bhardwaj R.; Parker M.C.; Modern perspectives in the treatment of chronic anal fissures. Ann R Coll Surg Engl 2007,89(5),472-478","journal-title":"Ann R Coll Surg Engl"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/BF02234624","volume":"44","author":"Jonas M.","year":"2001","unstructured":"Jonas M.; Neal K.R.; Abercrombie J.F.; Scholefield J.H.; A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum 2001,44(8),1074-1078","journal-title":"Dis Colon Rectum"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10350-004-0693-x","volume":"47","author":"Lindsey I.","year":"2004","unstructured":"Lindsey I.; Cunningham C.; Jones O.M.; Francis C.; Mortensen N.J.; Fissurectomy-botulinum toxin: A novel sphincter-sparing procedure for medically resistant chronic anal fissure. Dis Colon Rectum 2004,47(11),1947-1952","journal-title":"Dis Colon Rectum"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00384-005-0766-x","volume":"21","author":"Katsinelos P.","year":"2006","unstructured":"Katsinelos P.; Papaziogas B.; Koutelidakis I.; Paroutoglou G.; Dimiropoulos S.; Souparis A.; Atmatzidis K.; Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: Long-term follow-up. Int J Colorectal Dis 2006,21(2),179-183","journal-title":"Int J Colorectal Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/j.1572-0241.2007.01203.x","volume":"102","author":"Dhawan S.","year":"2007","unstructured":"Dhawan S.; Chopra S.; Nonsurgical approaches for the treatment of anal fissures. Am J Gastroenterol 2007,102(6),1312-1321","journal-title":"Am J Gastroenterol"},{"key":"ref=12","first-page":"295","volume":"48","author":"Golfam F.","year":"2010","unstructured":"Golfam F.; Golfam P.; Khalaj A.; Sayed Mortaz S.S.; The effect of topical nifedipine in treatment of chronic anal fissure. Acta Med Iran 2010,48(5),295-299","journal-title":"Acta Med Iran"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/BF02236693","volume":"42","author":"Antropoli C.","year":"1999","unstructured":"Antropoli C.; Perrotti P.; Rubino M.; Martino A.; De Stefano G.; Migliore G.; Antropoli M.; Piazza P.; Nifedipine for local use in conservative treatment of anal fissures: Preliminary results of a multicenter study. Dis Colon Rectum 1999,42(8),1011-1015","journal-title":"Dis Colon Rectum"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/BF02236630","volume":"43","author":"Carapeti E.A.","year":"2000","unstructured":"Carapeti E.A.; Kamm M.A.; Phillips R.K.; Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000,43(10),1359-1362","journal-title":"Dis Colon Rectum"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10350-004-6660-8","volume":"46","author":"Ezri T.","year":"2003","unstructured":"Ezri T.; Susmallian S.; Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003,46(6),805-808","journal-title":"Dis Colon Rectum"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-3-540-69419-9_20","author":"Lindsey I.","year":"2010","unstructured":"Lindsey I.;  Anal FissureAnorectal and Colonic Diseases; Givel, J-CR; Mortensen, N 2010,325-337","journal-title":"Anal FissureAnorectal and Colonic Diseases; Givel, J-CR; Mortensen, N"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1023\/A:1012091231023","volume":"14","author":"Jones D.S.","year":"1997","unstructured":"Jones D.S.; Woolfson A.D.; Brown A.F.; Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 1997,14(4),450-457","journal-title":"Pharm Res"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1201\/9780824744694.ch8","author":"Flynn G.L.","year":"2002","unstructured":"Flynn G.L.; Cutaneous and transdermal delivery-Processes and systems of delivery. Modern Pharmaceutics 2002","journal-title":"Modern Pharmaceutics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1201\/b14194-22","author":"Pena L.E.","year":"1989","unstructured":"Pena L.E.;  Gel dosage forms: Theory, Formulation, and processing Topical Drug Delivery Formulations; Osborne, DW 1989,381-388","journal-title":"Gel dosage forms: Theory, Formulation, and processing Topical Drug Delivery Formulations; Osborne, DW"},{"key":"ref=20","year":"2018","unstructured":"The International Pharmacopoeia2018"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1201\/9780824743239.ch7","author":"Walters K.A.","year":"2002","unstructured":"Walters K.A.; Brain K.R.;  Dermatological and Transdermal Formulations 2002","journal-title":"Dermatological and Transdermal Formulations"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cocis.2011.05.005","volume":"16","author":"Dassanayake L.S.K.","year":"2011","unstructured":"Dassanayake L.S.K.; Kodali D.R.; Ueno S.; Formation of oleogels based on edible lipid materials. Curr Opin Colloid Interface Sci 2011,16,432-439","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.foodres.2012.05.020","volume":"48","author":"Gravelle A.J.","year":"2012","unstructured":"Gravelle A.J.; Barbut S.; Marangoni A.G.; Ethylcellulose oleogels: Manufacturing considerations and effects of oil oxidation. Food Res Int 2012,48,578-583","journal-title":"Food Res Int"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.foostr.2014.07.002","volume":"2","author":"Zetzl A.K.","year":"2014","unstructured":"Zetzl A.K.; Gravelle A.J.; Kurylowicz M.; Dutcher J.; Barbut S.; Marangoni A.G.; Microstructure of ethylcellulose oleogels and its relationship to mechanical properties. Food Structure 2014,2,27-40","journal-title":"Food Structure"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/03639049209043696","volume":"18","author":"Baykara T.","year":"1992","unstructured":"Baykara T.; Yuksel N.; The preparation of prolonged action formulations in the form of semi solid matrix into hard gelatin capsules of oxprenolol II. Thixocap method. Drug Dev Ind Pharm 1992,18,233-243","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1023\/B:PHAM.0000033006.11619.07","volume":"21","author":"Islam M.T.","year":"2004","unstructured":"Islam M.T.; Rodr\u00edguez-Hornedo N.; Ciotti S.; Ackermann C.; Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res 2004,21(7),1192-1199","journal-title":"Pharm Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1023\/A:1015853223929","volume":"8","author":"Chu J.S.","year":"1991","unstructured":"Chu J.S.; Amidon G.L.; Weiner N.D.; Goldberg A.H.; Mixture experimental design in the development of a mucoadhesive gel formulation. Pharm Res 1991,8(11),1401-1407","journal-title":"Pharm Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijpharm.2004.06.012","volume":"282","author":"Bonacucina G.","year":"2004","unstructured":"Bonacucina G.; Martelli S.; Palmieri G.F.; Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm 2004,282(1-2),115-130","journal-title":"Int J Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1007\/s11095-005-8244-2","volume":"22","year":"2005","unstructured":"R.; Sirivat, A.; Vayumhasuwan, P. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases. Pharm Res A-sasutjarit2005,22(12),2134-2140","journal-title":"Pharm Res"},{"key":"ref=30","year":"2011","unstructured":"2011"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0378-5173(97)00282-2","volume":"159","author":"Squillante E.","year":"1997","unstructured":"Squillante E.; Needham T.; Zia H.; Solubility and in vitro transdermal permeation of nifedipine. Int J Pharm 1997,159,171-180","journal-title":"Int J Pharm"},{"key":"ref=32","year":"1997","unstructured":"Nonsterile Semisolid Dosage Forms, Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In vitro Release Testing and In vivo Bioequivalence Documentation Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry1997","journal-title":"Nonsterile Semisolid Dosage Forms, Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In vitro Release Testing and In vivo Bioequivalence Documentation Food and Drug Administration, Center for Drug Evaluation and Research"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-5173(99)00005-8","volume":"180","author":"Ocak F.","year":"1999","unstructured":"Ocak F.; A\u011fabeyo\u011flu I.; Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate. Int J Pharm 1999,180(2),177-183","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1208\/s12249-009-9369-0","volume":"11","author":"Jain D.","year":"2010","unstructured":"Jain D.; Pathak K.; Design, characterization, and evaluation of meloxicam gel prepared by suspension and solution polymerization using solubility parameter as the basis for development. AAPS PharmSciTech 2010,11(1),133-142","journal-title":"AAPS PharmSciTech"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-5173(98)00110-0","volume":"169","author":"Squillante E.","year":"1998","unstructured":"Squillante E.; Maniar A.; Needham T.; Zia H.; Optimization of in vitro nifedipine penetration enhancement through hairless mouse skin. Int J Pharm 1998,169,143-154","journal-title":"Int J Pharm"},{"key":"ref=36","year":"2008","unstructured":"EMA - European Medicines Agency2008"},{"key":"ref=37","first-page":"64","author":"Moore J.W.","year":"1996","unstructured":"Moore J.W.; Flanner H.H.; Mathematical comparison of dissolution profiles. Pharm Technol 1996((June)),64-74","journal-title":"Pharm Technol"},{"key":"ref=38","year":"2011","unstructured":"Clinical and Laboratory Standards Institute CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement CLSI document M100- S21 (ISBN 1-56238-742-1)Wayne, PA, 19087 USA 2011","journal-title":"Clinical and Laboratory Standards Institute"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000321038","author":"Elsner P.","unstructured":"Elsner P.; 2011 40, pp. Anatomical and physiological basis of topical therapy of the mucosa.  Topical Applications and the Mucosa Curr\nProbl Dermatol Basel, Karger ,1-8","journal-title":"Topical Applications and the Mucosa Curr\nProbl Dermatol Basel, Karger"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0031-6865(96)00022-2","volume":"71","author":"McDaid D.M.","year":"1996","unstructured":"McDaid D.M.; Deasy P.B.; An investigation into the transdermal delivery of nifedipine. Pharm Acta Helv 1996,71(4),253-258","journal-title":"Pharm Acta Helv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/01.RES.66.5.1449","volume":"66","author":"Mak I.T.","year":"1990","unstructured":"Mak I.T.; Weglicki W.B.; Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990,66(5),1449-1452","journal-title":"Circ Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/080370598438999","volume":"2","author":"van Zwieten P.A.","year":"1998","unstructured":"van Zwieten P.A.; The pharmacological properties of lipophilic calcium antagonists. Blood Press Suppl 1998,2,5-9","journal-title":"Blood Press Suppl"},{"key":"ref=43","first-page":"104","volume":"4","author":"Divani M.J.","year":"2012","unstructured":"Divani M.J.; Patel K.R.; Patel N.M.; Rev\u0131ew: Advanced apporoches in semisolid. Int J Pharm Tech Res 2012,4,104-115","journal-title":"Int J Pharm Tech Res"},{"key":"ref=44","author":"Block L.H.","year":"2000","unstructured":"Block L.H.;  Remington: The Science and Practice of Pharmacy 2000","journal-title":"Remington: The Science and Practice of Pharmacy"},{"key":"ref=45","first-page":"863","volume":"2","author":"Sanna V.","year":"2010","unstructured":"Sanna V.; Peana A.T.; Moretti M.D.L.; Development of new topical formulations of diphenhydramine hydrochloride: In vitro diffusion and in vivo preliminary studies. Int J Pharm Tech Res 2010,2,863-869","journal-title":"Int J Pharm Tech Res"},{"key":"ref=46","author":"Sinko J.P.","year":"2011","unstructured":"Sinko J.P.; Singh Y.;  Martin\u2019s Physical Pharmacy and Pharmaceutical Sciences 2011","journal-title":"Martin\u2019s Physical Pharmacy and Pharmaceutical Sciences"},{"key":"ref=47","first-page":"453","author":"Martin A.","year":"1993","unstructured":"Martin A.; Bustamante P.; Chun A.H.C.;  Physical pharmacy 1993,453-476","journal-title":"Physical pharmacy"},{"key":"ref=48","unstructured":""},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"E504","DOI":"10.1208\/pt060363","volume":"6","author":"Devarakonda B.","year":"2005","unstructured":"Devarakonda B.; Li N.; de Villiers M.M.; Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels. AAPS PharmSciTech 2005,6(3),E504-E512","journal-title":"AAPS PharmSciTech"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2306\/scienceasia1513-1874.2006.32.429","volume":"32","author":"Rahman N.","year":"2006","unstructured":"Rahman N.; Azmi S.N.; Validated spectrophotometric method for the assay of nifedipine in bulk and commercial dosage forms. Sci Asia 2006,32,429-435","journal-title":"Sci Asia"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/app.42761","volume":"132","author":"Lefran\u00e7ois P.","year":"2015","unstructured":"Lefran\u00e7ois P.; Ibarboure E.; Payr\u00e9 B.; Gontier E.; Le Meins J-F.; Schatz C.; Insights into carbopol gel formulations: Microscopy analysis of the microstructure and the influence of polyol additives. J Appl Polym Sci 2015,132,1-7","journal-title":"J Appl Polym Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1081\/DDC-100100358","volume":"26","author":"Shin S.C.","year":"2000","unstructured":"Shin S.C.; Kim J.Y.; Oh I.J.; Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Dev Ind Pharm 2000,26(3),307-312","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10717540701829234","volume":"15","author":"Cevher E.","year":"2008","unstructured":"Cevher E.; Taha M.A.; Orlu M.; Araman A.; Evaluation of mechanical and mucoadhesive properties of clomiphene citrate gel formulations containing carbomers and their thiolated derivatives. Drug Deliv 2008,15(1),57-67","journal-title":"Drug Deliv"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3109\/10837450.2010.508074","volume":"16","author":"Baloglu E.","year":"2011","unstructured":"Baloglu E.; Karavana S.Y.; Senyigit Z.A.; Guneri T.; Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharm Dev Technol 2011,16(6),627-636","journal-title":"Pharm Dev Technol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0378-5173(97)04904-1","volume":"151","author":"Jones D.S.","year":"1997","unstructured":"Jones D.S.; Woolfson A.D.; Brown A.F.; Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 1997,151,223-233","journal-title":"Int J Pharm"},{"key":"ref=56","year":"2007","unstructured":"US Pharmacopeial Convention, Rockville, MD, Chapter 905 US Pharmacopeia2007"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/178025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T07:04:51Z","timestamp":1585379091000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/178025\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201817666200102125242","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}